Literature DB >> 18038233

Initial experience on efficacy in closure of cryptoglandular and Crohn's transsphincteric fistulas by the use of the anal fistula plug.

O Schwandner1, F Stadler, O Dietl, R P Wirsching, A Fuerst.   

Abstract

BACKGROUND AND AIMS: It was the aim of this prospective study to analyze the efficacy of the Cook Surgisis AFP anal fistula plug (AFP) for the closure of cryptoglandular and Crohn's disease-associated transsphincteric anorectal fistulas.
MATERIALS AND METHODS: All patients with transsphincteric anorectal fistulas who underwent a surgical procedure using the AFP were prospectively enrolled in this study. Inclusion criteria included transsphincteric, single-tract fistulas. Patients' demographics, fistula etiology, surgical variables, continence (Cleveland Clinic Florida incontinence score), quality of life (fecal incontinence quality of life), and success rates were prospectively recorded. Surgery was performed in a standardized technique including irrigation of the fistula tract, placement, and internal fixation of the Cook Surgisis AFP anal fistula plug. No flap or excision of the fistula tract was performed. Success was defined as closure of both internal and external openings, absence of drainage without further intervention, and absence of abscess formation. Follow-up information was derived from clinical examination 3, 6, 9, and 12 months postoperatively.
RESULTS: Within 6 months (August 2006 to January 2007), a total of 19 AFPs were inserted in 19 patients (8 females, 11 males; mean age, 38 years). Out of 19 patients, 12 had cryptoglandular and 7 had Crohn's associated transsphincteric fistulas. Three patients were smokers, one patient had methicillin-resistant Staphylococcus aureus infection. Mean operative time was 15 min (range, 8-22); no morbidity occurred. After a mean follow-up of 279 days (SD = 68.0) and one patient lost to follow-up, the overall success rate was 61% (12 of 18) at 9 months postoperatively. Focusing solely on cryptoglandular fistulas, the success rate was 45.5% (5 of 11), whereas it was 85.7% (6 of 7) in transsphincteric fistulas associated with Crohn's disease. Five patients with failure of AFP (plug dislodgement, n = 2; persistent secretion, n = 3) had reoperation (27.8%). The reasons for failure were infection requiring drainage (n = 2) and persistent drainage (n = 3). No deterioration of continence was documented.
CONCLUSION: The success rate for the Cook Surgisis AFP anal fistula plug for the closure of complex anorectal fistulas both in cryptoglandular and Crohn's associated fistulas was 45.5 and 85.7%, respectively. Further analysis is needed to explain the definite role of this innovative technique in comparison to traditional surgical techniques.

Entities:  

Mesh:

Year:  2007        PMID: 18038233     DOI: 10.1007/s00384-007-0398-4

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  21 in total

1.  Fecal Incontinence Quality of Life Scale: quality of life instrument for patients with fecal incontinence.

Authors:  T H Rockwood; J M Church; J W Fleshman; R L Kane; C Mavrantonis; A G Thorson; S D Wexner; D Bliss; A C Lowry
Journal:  Dis Colon Rectum       Date:  2000-01       Impact factor: 4.585

2.  Pathogenesis and treatment of fistuila-in-ano.

Authors:  A G PARKS
Journal:  Br Med J       Date:  1961-02-18

3.  Fibrin glue treatment of complex anal fistulas has low success rate.

Authors:  Rasmy Loungnarath; David W Dietz; Matthew G Mutch; Elisa H Birnbaum; Ira J Kodner; James W Fleshman
Journal:  Dis Colon Rectum       Date:  2004-02-25       Impact factor: 4.585

4.  Efficacy of anal fistula plug in closure of Crohn's anorectal fistulas.

Authors:  Lynn O'Connor; Bradley J Champagne; Martha A Ferguson; Guy R Orangio; Marion E Schertzer; David N Armstrong
Journal:  Dis Colon Rectum       Date:  2006-10       Impact factor: 4.585

5.  Fibrin glue as an adjunct to flap repair of anal fistulas: a randomized, controlled study.

Authors:  C Neal Ellis; Stephen Clark
Journal:  Dis Colon Rectum       Date:  2006-11       Impact factor: 4.585

6.  A randomized, controlled trial of fibrin glue vs. conventional treatment for anal fistula.

Authors:  Ian Lindsey; M M Smilgin-Humphreys; Chris Cunningham; Neil J M Mortensen; Bruce D George
Journal:  Dis Colon Rectum       Date:  2002-12       Impact factor: 4.585

7.  Practice parameters for the treatment of perianal abscess and fistula-in-ano (revised).

Authors:  Mark H Whiteford; John Kilkenny; Neil Hyman; W Donald Buie; Jeffrey Cohen; Charles Orsay; Gary Dunn; W Brian Perry; C Neal Ellis; Jan Rakinic; Sharon Gregorcyk; Paul Shellito; Richard Nelson; Joe J Tjandra; Graham Newstead
Journal:  Dis Colon Rectum       Date:  2005-07       Impact factor: 4.585

8.  Treatment of fistulas-in-ano with fibrin sealant in combination with intra-adhesive antibiotics and/or surgical closure of the internal fistula opening.

Authors:  Marc Singer; José Cintron; Richard Nelson; Charles Orsay; Amir Bastawrous; Russell Pearl; Julia Sone; Herand Abcarian
Journal:  Dis Colon Rectum       Date:  2005-04       Impact factor: 4.585

9.  Repair of fistulas-in-ano using fibrin adhesive: long-term follow-up.

Authors:  J R Cintron; J J Park; C P Orsay; R K Pearl; R L Nelson; J H Sone; R Song; H Abcarian
Journal:  Dis Colon Rectum       Date:  2000-07       Impact factor: 4.585

10.  Efficacy of fibrin sealant in the management of complex anal fistula: a prospective trial.

Authors:  Gordon N Buchanan; Clive I Bartram; Robin K S Phillips; Stuart W T Gould; Steve Halligan; Tim A Rockall; Paul Sibbons; Richard G Cohen
Journal:  Dis Colon Rectum       Date:  2003-09       Impact factor: 4.585

View more
  29 in total

Review 1.  Managing Perianal Crohn’s Disease.

Authors:  Dawn M Wiese; David A Schwartz
Journal:  Curr Gastroenterol Rep       Date:  2012-04

2.  Surgery: Are bioprosthetic plugs for complex anal fistulas effective?

Authors:  Oliver Schwandner
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-08       Impact factor: 46.802

3.  Experimental comparison of abdominal wall repair using different methods of enhancement by small intestinal submucosa graft.

Authors:  Yves Ozog; Maja L Konstantinovic; Sofie Verschueren; Federico Spelzini; Dirk De Ridder; Jan Deprest
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2009-01-13

4.  Controversies in fistula in ano.

Authors:  Parvez Sheikh
Journal:  Indian J Surg       Date:  2012-06-29       Impact factor: 0.656

Review 5.  Emerging treatments for complex perianal fistula in Crohn's disease.

Authors:  Carlos Taxonera; David A Schwartz; Damián García-Olmo
Journal:  World J Gastroenterol       Date:  2009-09-14       Impact factor: 5.742

Review 6.  Modern management of anal fistula.

Authors:  Elsa Limura; Pasquale Giordano
Journal:  World J Gastroenterol       Date:  2015-01-07       Impact factor: 5.742

7.  Management of Fistula-in-Ano-The Current Evidence.

Authors:  Parvez Sheikh; Atef Baakza
Journal:  Indian J Surg       Date:  2014-08-15       Impact factor: 0.656

Review 8.  The treatment of anal fistulas with biologically derived products: is innovation better than conventional surgical treatment? An update.

Authors:  Roberto Cirocchi; Stefano Trastulli; Umberto Morelli; Jacopo Desiderio; Carlo Boselli; Amilcare Parisi; Giuseppe Noya
Journal:  Tech Coloproctol       Date:  2012-12-04       Impact factor: 3.781

Review 9.  [Fistulas and fissures. Part I: perianal fistulas].

Authors:  W Heitland
Journal:  Chirurg       Date:  2008-05       Impact factor: 0.955

10.  Small intestinal submucosa for reinforcement of colonic anastomosis.

Authors:  Jens Hoeppner; Vladan Crnogorac; Goran Marjanovic; Eva Jüttner; Tobias Keck; Hans-Fred Weiser; Ullrich Theodor Hopt
Journal:  Int J Colorectal Dis       Date:  2009-01-30       Impact factor: 2.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.